INSM

Insmed Inc

Apr 09 • 04:00PM ET

159.59

-0.59 -0.37 %

Healthcare • Biotechnology • USA • NASD

Peers: VRTX BIIB REGN GILD RARE NBIX UTHR SRPT EXEL BMRN

| Held by: VTI QQQ VB VXF VO IBB VUG IWP VBK QQQM

Index	NDX	P/E	-	EPS (ttm)	-6.40	Insider Own	1.15%	Shs Outstand	214.26M	Perf Week	-3.20%
Market Cap	34.40B	Forward P/E	145.65	EPS next Y	1.10	Insider Trans	-19.54%	Shs Float	213.06M	Perf Month	10.94%
Enterprise Value	33.73B	PEG	-	EPS next Q	-0.99	Inst Own	99.19%	Short Float	4.71%	Perf Quarter	-9.32%
Income	-1.28B	P/S	56.73	EPS this Y	59.65%	Inst Trans	-0.56%	Short Ratio	3.91	Perf Half Y	-1.68%
Sales	606.42M	P/B	46.27	EPS next Y	142.30%	ROA	-59.53%	Short Interest	10.04M	Perf YTD	-8.30%
Book/sh	3.45	P/C	24.06	EPS next 5Y	-	ROE	-249.28%	52W High	212.75 -24.99%	Perf Year	136.25%
Cash/sh	6.63	P/FCF	-	EPS past 3/5Y	-17.91% -16.32%	ROIC	-86.52%	52W Low	60.40 164.22%	Perf 3Y	848.25%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	35.20% 29.83%	Gross Margin	78.74%	Volatility	3.48% 3.93%	Perf 5Y	403.44%
Dividend TTM	-	EV/Sales	55.61	EPS Y/Y TTM	-14.62%	Oper. Margin	-164.04%	ATR (14)	6.32	Perf 10Y	1147.77%
Dividend Ex-Date	-	Quick Ratio	3.54	Sales Y/Y TTM	66.73%	Profit Margin	-210.54%	RSI (14)	57.58	Recom	1.14
Dividend Gr. 3/5Y	- -	Current Ratio	3.83	EPS Q/Q	-16.86%	SMA20	6.20%	Beta	1.11	Target Price	212.15
Payout	-	Debt/Eq	1.02	Sales Q/Q	152.62%	SMA50	5.99%	Rel Volume	0.61	Prev Close	160.18
Employees	1664	LT Debt/Eq	1.00	Earnings	Feb 19 BMO	SMA200	5.05%	Avg Volume	2.57M	Price	159.59
IPO	Feb 15, 1991	Option/Short	Yes / Yes	EPS/Sales Surpr.	-43.86% 14.10%	Trades		Volume	1,564,278	Change	-0.37%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-30-26	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$212
Mar-16-26	Resumed	Jefferies	Buy
Jan-28-26	Initiated	Barclays	Overweight	$231
Jan-23-26	Initiated	Roth Capital	Buy	$212
Dec-19-25	Resumed	Truist	Buy	$202
Dec-04-25	Initiated	Rothschild & Co Redburn	Buy	$263
Oct-28-25	Resumed	Cantor Fitzgerald	Overweight	$192
Oct-20-25	Initiated	Wells Fargo	Overweight	$171
Aug-20-25	Initiated	William Blair	Outperform
Aug-13-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$126
May-13-25	Initiated	Jefferies	Buy	$105
Feb-25-25	Initiated	RBC Capital Mkts	Outperform	$100
Apr-23-24	Initiated	Truist	Buy	$48
Feb-15-24	Initiated	Wolfe Research	Outperform	$42
Dec-08-23	Initiated	Wells Fargo	Overweight	$55
Nov-20-23	Resumed	JP Morgan	Overweight	$36
Jul-26-23	Initiated	Guggenheim	Buy	$50
Dec-09-22	Initiated	Mizuho	Buy	$28
Dec-07-22	Initiated	Barclays	Overweight	$37
Nov-18-22	Initiated	BofA Securities	Buy	$39

Show Previous Ratings

Apr-08-26 07:01AM	Insmed freezes Brinsupris HS programme on Phase II failure (Clinical Trials Arena)
05:37AM	Novo underprices Lilly with higher-dose Wegovy; Insmed absorbs expected study failure (BioPharma Dive)
Apr-07-26 04:01PM	Insmed Provides Clinical Update on Phase 2b CEDAR Study (PR Newswire)
Apr-01-26 01:05PM	Options Bulls Could Be Right About This Pharma Stock (Schaeffer's Research)
Mar-24-26 08:30AM	Insmed eyes Arikayce label expansion on Phase IIIb lung disease success (Clinical Trials Arena)
02:47PM	Loading…
Mar-23-26 02:47PM	Nasdaq and Dow lead markets higher as Trump claims Iran peace talks (Proactive) +5.87%
11:29AM	Insmed shares rise as Arikayce trial data point to larger market opportunity (Investing.com)
10:09AM	Insmed shares rise on positive late-stage trial results for lung disease therapy (Proactive)
07:00AM	Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease (PR Newswire)
06:16AM	FDA seeks feedback on voucher program; Study data lift overhang on Insmed shares (BioPharma Dive)
Mar-06-26 12:29PM	Insmed Incorporated (INSM) Price Target Raised to $211 at BofA (Insider Monkey)
Mar-05-26 07:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Mar-01-26 01:33AM	Insmed Incorporated (INSM) Enters 2026 With Momentum (Insider Monkey)
Feb-26-26 11:53PM	Why Insmed Incorporated (INSM) is One of the Best Strong Buy Healthcare Stocks to Invest In (Insider Monkey)
Feb-24-26 07:19AM	Insmed Incorporated (INSM) Gained from Its Lead Product ARIKAYCE (Insider Monkey)
10:20AM	Loading…
Feb-20-26 10:20AM	Insmed Lags on Q4 Earnings, Stock Gains on 2026 Brinsupri Sales View (Zacks)
09:55AM	Wall Street Analysts Think Insmed (INSM) Could Surge 33.6%: Read This Before Placing a Bet (Zacks)
03:44AM	Insmed (INSM) Poised for 2026 Upside With Potential $1.3B Arikayce Sales Boost, Roth/MKM Initiates Buy (Insider Monkey)
Feb-19-26 04:33PM	Stocks Decline Amid AI Fears and Geopolitical Risks (Barchart) +6.54%
02:03PM	Insmed Inc (INSM) Q4 2025 Earnings Call Highlights: Strong Brin Suri Launch and Promising 2026 ... (GuruFocus.com)
12:32PM	Insmed Incorporated Q4 2025 Earnings Call Summary (Moby)
09:36AM	Insmed Q4 Earnings Call Highlights (MarketBeat)
09:30AM	Insmed (INSM) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
08:10AM	Insmed (INSM) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
07:14AM	Insmed: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Insmed Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Business Update (PR Newswire)
Feb-16-26 02:11PM	What to Expect From These Drug/Biotech Players This Earnings Season? (Zacks)
10:00AM	Axsome Therapeutics (AXSM) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Feb-13-26 07:00AM	Insmed To Present at March 2026 Investor Conferences (PR Newswire)
Feb-12-26 10:00AM	Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
07:00AM	Loading…
Feb-05-26 07:00AM	Insmed to Host Fourth-Quarter and Full-Year 2025 Financial Results Conference Call on Thursday, February 19, 2026 (PR Newswire)
Feb-02-26 01:30AM	The Druckenmiller Connection: Meet the Man Behind Bessent and Warsh (Barrons.com)
Jan-28-26 07:00AM	Insmed to Present Multiple Abstracts on Treprostinil Palmitil Inhalation Powder (TPIP) at Pulmonary Vascular Research Institute (PVRI) 2026 Congress (PR Newswire)
Jan-23-26 07:50AM	Here Are Fridays Top Wall Street Analyst Research Calls: Applied Materials, e.l.f. Beauty, Fortinet, Freeport MacMoRan, Procter & Gamble, Spotify, and More (24/7 Wall St.)
Jan-19-26 01:04AM	Analyst Weighs Patent Cliff Risks Against Insmed's (INSM) Growth Story (Insider Monkey)
Jan-12-26 07:08PM	Insmed CEO Will Lewis talks its rare disease drug pipeline (CNBC TV)
09:32AM	INSM Stock Jumps on 2025 Preliminary Sales, 2026 Goals Announced (Zacks)
Jan-09-26 04:38PM	S&P 500 Rallies to a New Record High on US Economic Optimism (Barchart)
11:19AM	Healthcare dealmakers head to San Francisco hoping for megamergers in 2026 (Reuters)
10:58AM	Insmed Maps Aggressive 2026 As Newly Approved Lung Disease Drug Gains Traction, Pipeline Advances (Benzinga)
09:44AM	Stock Market Today: Dow Up After Surprise Jobs Data; Trump Tariff Ruling Looms (Live Coverage) (Investor's Business Daily)
07:00AM	Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
06:28AM	Insmeds ginormous lung drug sales; J&Js US pricing deal (BioPharma Dive)
Jan-08-26 07:20AM	Jim Cramer on Insmed: "This One Is Worth Keeping an Eye On" (Insider Monkey)
Jan-05-26 10:19AM	Stock Market Today: Dow Jumps After U.S. Ousts Maduro; Energy Shines, Nvidia Rallies Ahead (Live Coverage) (Investor's Business Daily)
09:01AM	Bet on These 3 Small-Cap ETFs to Ride the January Effect (Zacks)
Jan-02-26 08:15AM	INSM Stock Up 78% in 6 Months: Here's What You Need to Know (Zacks)
07:00AM	Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-31-25 09:01AM	Ultragenyx (RARE) Moves 15.5% Higher: Will This Strength Last? (Zacks)
Dec-30-25 04:31PM	Stocks Fall Slightly in Thin Holiday Trade (Barchart)
11:06AM	Stocks Slip as Bond Yields Rise (Barchart)
Dec-26-25 02:33AM	The Zacks Analyst Blog Mineralys, Lyell, Insmed and Nektar (Zacks)
Dec-24-25 10:51AM	4 Drug, Biotech Stocks Rising More Than 50% in 2025 With Room to Grow (Zacks)
Dec-18-25 06:15PM	Mizuho's Jared Holz talks Insmed sinking double digits on sinus drug trial news (CNBC TV) -16.08%
04:33PM	Stocks Settle Higher on Upbeat Tech Outlook and Cooling Inflation (Barchart)
04:15PM	The 'Worst-Case Scenario' Why Insmed Just Reversed After A 181% Six-Month Sprint (Investor's Business Daily)
04:13PM	These Stocks Moved the Most Today: Micron, DJT, Accenture, Tilray, Lululemon, Medline, Rivian, and More (Barrons.com)
03:13PM	These Stocks Are Moving the Most Today: Micron, DJT, Accenture, Tilray, Lululemon, Medline, Rivian, and More (Barrons.com)
07:59AM	INSM Stock Plummets on Sinus Study Failure, Adds New Pipeline Asset (Zacks)
07:12AM	Insmed Stock Plummets 19%. This Is What Sparked the Selloff. (Barrons.com)
06:10AM	These Stocks Are Moving the Most Today: Micron, Sandisk, Lululemon, Insmed, Rivian, PayPal, and More (Barrons.com)
06:02AM	Insmeds win streak ends as top drug fails study in chronic nasal condition (BioPharma Dive)
Dec-17-25 04:01PM	Insmed Provides Clinical and Business Update (PR Newswire)
Dec-15-25 12:15PM	MicroStrategy retains place in key index despite delisting threats (TheStreet)
09:11AM	Western Digital stock rises after inclusion in Nasdaq-100 Index (Investing.com)
07:03AM	200% Surge? These 6 Stocks Just Crashed the Nasdaq 100 Party (GuruFocus.com)
Dec-13-25 11:04AM	Walmart was too late for a Nasdaq-100 spot - but these 6 stocks made the cut (MarketWatch)
Dec-12-25 08:21PM	Bitcoin hoarding company Strategy remains in Nasdaq 100 (Reuters)
Dec-11-25 10:11AM	Crypto Market 2026 Predictions: Which Coins Will 10x and Which Will Crash? (24/7 Wall St.)
10:11AM	Billionaire Stanley Druckenmiller is Betting $1.2 Billion in These 3 Stocks (24/7 Wall St.)
Dec-10-25 11:30AM	Immunovant (IMVT) Down 0.6% Since Last Earnings Report: Can It Rebound? (Zacks)
Dec-04-25 11:30AM	Why Is Amgen (AMGN) Up 8% Since Last Earnings Report? (Zacks)
07:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Nov-30-25 03:14AM	30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks (Motley Fool)
Nov-28-25 10:07AM	Biotechs Are On A Big Run, And Two Stocks Have Buy Points (Investor's Business Daily)
Nov-25-25 07:35AM	Insmed (INSM) Rose Following Drug Approval (Insider Monkey)
Nov-24-25 12:38PM	This Investor Beat the Market for 3 Decades Without a Single Losing Year. 3 Stocks Hes Buying Now. (24/7 Wall St.)
Nov-20-25 03:45PM	These 15 stocks are still showing momentum - and a market-beating edge (MarketWatch)
Nov-19-25 10:59AM	Insmed Stock Rise on EU Nod for Lung Disease Drug, Brinsupri (Zacks)
05:03AM	Insmed receives EC approval for Brinsupri to treat NCFB (Pharmaceutical Business Review)
Nov-18-25 11:06AM	European Commission Approves BRINSUPRI (brensocatib) as the First and Only Treatment To Date Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union (PR Newswire)
11:00AM	European Commission Approves BRINSUPRI (brensocatib) as the First and Only Treatment Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union (PR Newswire)
Nov-17-25 10:10AM	Here's What Lifted Insmed Incorporated (INSM) in Q3 (Insider Monkey)
Nov-13-25 07:00AM	Insmed Strengthens Communities Worldwide During Fourth Annual Global Day of Good (PR Newswire)
Nov-05-25 07:00AM	Insmed To Present at November and December 2025 Investor Conferences (PR Newswire)
Nov-03-25 07:06PM	Latest read on rare disease gene therapy from Insmed CEO Will Lewis (CNBC TV)
09:16AM	Approval of Brinsupri Lifted Insmed Incorporated (INSM) in Q3 (Insider Monkey)
Oct-31-25 10:03AM	Insmed (INSM) Hits All-Time High as Firm Posts Highly Optimistic Outlook (Insider Monkey)
08:58AM	Insmed Misses on Q3 Earnings, Stock Rises on Strong Brinsupri Uptake (Zacks)
Oct-30-25 04:21PM	Insmed Inc (INSM) Q3 2025 Earnings Call Highlights: Strong Launch for Brin Suri and Robust ... (GuruFocus.com) +16.33%
04:12PM	Insmed Screams To A 25-Year High, While IBD 50's Argenx Slides (Investor's Business Daily)
08:46AM	Insmed Catapults While IBD 50's Argenx Creeps Higher On Bullish Reports (Investor's Business Daily)
08:20AM	Insmed (INSM) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
07:17AM	Insmed: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Insmed Reports Third-Quarter 2025 Financial Results and Provides Business Update (PR Newswire)
05:08AM	Apple and Amazon headline earnings slate (MarketWatch)
04:29AM	Stock Market Today: Dow, S&P 500 and Nasdaq hover near record highs after U.S.-China trade deal, while Meta stock dives but Alphabet pops on earnings; Apple and Amazon results on tap; Treasury yields up on December rate-cut pushback. (MarketWatch)
Oct-29-25 04:14PM	United Therapeutics Rockets 10% On Growing Enthusiasm For Its Top Drug (Investor's Business Daily)
09:55AM	The Mixed Results For United Therapeutics' Bread-And-Butter Drug (Investor's Business Daily)
09:15AM	Gear Up for Insmed (INSM) Q3 Earnings: Wall Street Estimates for Key Metrics (Zacks)

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lewis William	Chair and CEO	Apr 06 '26	Option Exercise	24.94	10,699	266,840	311,884	Apr 08 04:41 PM
Lewis William	Chair and CEO	Apr 06 '26	Sale	163.22	10,699	1,746,336	301,185	Apr 08 04:41 PM
William Lewis	Officer	Apr 06 '26	Proposed Sale	163.22	10,699	1,746,319		Apr 06 04:42 PM
Adsett Roger	Chief Operating Officer	Apr 01 '26	Option Exercise	14.56	88,060	1,282,154	194,870	Apr 03 04:07 PM
Adsett Roger	Chief Operating Officer	Apr 01 '26	Sale	164.63	88,060	14,497,651	106,810	Apr 03 04:07 PM
Roger Adsett	Officer	Apr 01 '26	Proposed Sale	164.27	88,060	14,465,616		Apr 01 05:10 PM
Smith Michael Alexander	Chief Legal Officer	Mar 30 '26	Option Exercise	24.78	19,638	486,582	71,509	Mar 31 04:13 PM
Smith Michael Alexander	Chief Legal Officer	Mar 30 '26	Sale	150.98	19,638	2,964,945	51,871	Mar 31 04:13 PM
Michael Smith	Officer	Mar 30 '26	Proposed Sale	150.98	19,638	2,964,929		Mar 30 05:31 PM
Lewis William	Chair and CEO	Mar 19 '26	Option Exercise	24.94	10,699	266,840	311,884	Mar 20 04:05 PM
Lewis William	Chair and CEO	Mar 19 '26	Sale	143.52	10,699	1,535,542	301,185	Mar 20 04:05 PM
William Lewis	Officer	Mar 19 '26	Proposed Sale	143.52	10,699	1,535,514		Mar 19 04:57 PM
William Lewis	Officer	Mar 05 '26	Proposed Sale	146.02	10,699	1,562,311		Mar 05 04:59 PM
Lewis William	Chair and CEO	Mar 05 '26	Option Exercise	24.94	10,699	266,840	311,884	Mar 05 04:16 PM
Lewis William	Chair and CEO	Mar 05 '26	Sale	146.03	10,699	1,562,328	301,185	Mar 05 04:16 PM
Smith Michael Alexander	Chief Legal Officer	Feb 24 '26	Option Exercise	17.07	20,248	345,633	76,645	Feb 25 04:04 PM
Smith Michael Alexander	Chief Legal Officer	Feb 24 '26	Sale	155.77	24,774	3,859,157	51,871	Feb 25 04:04 PM
Michael Smith	Officer	Feb 24 '26	Proposed Sale	155.77	24,774	3,859,153		Feb 24 04:33 PM
Lewis William	Chair and CEO	Feb 19 '26	Option Exercise	24.94	10,699	266,840	311,884	Feb 23 04:34 PM
Lewis William	Chair and CEO	Feb 19 '26	Sale	150.97	10,699	1,615,257	301,185	Feb 23 04:34 PM
William Lewis	Officer	Feb 19 '26	Proposed Sale	150.97	10,699	1,615,250		Feb 19 04:54 PM
Lewis William	Chair and CEO	Feb 09 '26	Option Exercise	24.94	10,699	266,840	314,581	Feb 11 04:42 PM
Lewis William	Chair and CEO	Feb 09 '26	Sale	147.79	13,396	1,979,764	301,185	Feb 11 04:42 PM
William Lewis	Officer	Feb 09 '26	Proposed Sale	147.79	13,396	1,979,774		Feb 09 05:32 PM
Flammer Martina M.D.	Chief Medical Officer	Feb 05 '26	Sale	152.44	869	132,470	83,243	Feb 06 04:18 PM
Martina Flammer	Officer	Feb 05 '26	Proposed Sale	152.43	869	132,462		Feb 05 05:12 PM
Adsett Roger	Chief Operating Officer	Feb 03 '26	Sale	156.17	791	123,530	106,810	Feb 04 04:20 PM
Bonstein Sara	Chief Financial Officer	Feb 03 '26	Sale	156.34	748	116,942	79,758	Feb 04 04:19 PM
Lewis William	Chair and CEO	Feb 03 '26	Sale	156.34	3,009	470,427	303,882	Feb 04 04:17 PM
Smith Michael Alexander	Chief Legal Officer	Feb 03 '26	Sale	156.27	640	100,013	56,397	Feb 04 04:15 PM
Flammer Martina M.D.	Chief Medical Officer	Feb 02 '26	Option Exercise	65.72	7,982	524,577	92,889	Feb 04 04:15 PM
Flammer Martina M.D.	Chief Medical Officer	Feb 02 '26	Sale	154.59	7,982	1,233,959	84,907	Feb 04 04:15 PM
Flammer Martina M.D.	Chief Medical Officer	Feb 03 '26	Sale	155.77	795	123,837	84,112	Feb 04 04:15 PM
Roger Adsett	Officer	Feb 03 '26	Proposed Sale	156.16	791	123,526		Feb 03 05:04 PM
Michael Smith	Officer	Feb 03 '26	Proposed Sale	156.27	640	100,012		Feb 03 05:02 PM
William Lewis	Officer	Feb 03 '26	Proposed Sale	156.33	3,009	470,412		Feb 03 04:58 PM
Martina Flammer	Officer	Feb 03 '26	Proposed Sale	155.77	795	123,837		Feb 03 04:56 PM
Sara Bonstein	Officer	Feb 03 '26	Proposed Sale	156.33	748	116,938		Feb 03 04:55 PM
Martina Flammer	Officer	Feb 02 '26	Proposed Sale	154.59	7,982	1,233,964		Feb 02 05:30 PM
Lewis William	Chair and CEO	Jan 20 '26	Option Exercise	24.94	10,699	266,840	317,590	Jan 22 04:28 PM
Lewis William	Chair and CEO	Jan 20 '26	Sale	158.93	10,699	1,700,411	306,891	Jan 22 04:28 PM
William Lewis	Officer	Jan 20 '26	Proposed Sale	158.93	10,699	1,700,420		Jan 20 04:33 PM
Lewis William	Chair and CEO	Jan 12 '26	Option Exercise	24.94	10,699	266,840	326,106	Jan 13 04:04 PM
Lewis William	Chair and CEO	Jan 12 '26	Sale	169.00	19,215	3,247,349	306,891	Jan 13 04:04 PM
Flammer Martina M.D.	Chief Medical Officer	Jan 09 '26	Sale	186.19	1,887	351,341	84,907	Jan 13 04:03 PM
William Lewis	Officer	Jan 12 '26	Proposed Sale	169.00	19,215	3,247,325		Jan 12 04:58 PM
Sara Bonstein	Officer	Jan 08 '26	Proposed Sale	174.17	1,447	252,023		Jan 08 05:40 PM
Martina Flammer	Officer	Jan 08 '26	Proposed Sale	174.17	5,138	894,885		Jan 08 05:35 PM
Martina Flammer	Officer	Jan 08 '26	Proposed Sale	173.90	1,660	288,674		Jan 08 05:28 PM
Roger Adsett	Officer	Jan 08 '26	Proposed Sale	174.17	2,059	358,616		Jan 08 05:23 PM
Adsett Roger	Chief Operating Officer	Jan 08 '26	Sale	174.17	2,059	358,616	107,601	Jan 08 05:22 PM
Adsett Roger	Chief Operating Officer	Jan 06 '26	Sale	173.33	1,429	247,689	110,462	Jan 08 05:22 PM
Adsett Roger	Chief Operating Officer	Jan 07 '26	Sale	175.07	802	140,406	109,660	Jan 08 05:22 PM
Bonstein Sara	Chief Financial Officer	Jan 07 '26	Sale	175.07	1,678	293,767	81,953	Jan 08 05:21 PM
Bonstein Sara	Chief Financial Officer	Jan 06 '26	Sale	173.33	1,517	262,942	83,631	Jan 08 05:21 PM
Bonstein Sara	Chief Financial Officer	Jan 08 '26	Sale	174.17	1,447	252,024	80,506	Jan 08 05:21 PM
Flammer Martina M.D.	Chief Medical Officer	Jan 06 '26	Option Exercise	26.43	8,570	226,505	103,324	Jan 08 05:20 PM
Flammer Martina M.D.	Chief Medical Officer	Jan 06 '26	Sale	173.80	10,185	1,770,134	93,139	Jan 08 05:20 PM
Flammer Martina M.D.	Chief Medical Officer	Jan 08 '26	Sale	174.07	4,911	854,851	86,794	Jan 08 05:20 PM
Flammer Martina M.D.	Chief Medical Officer	Jan 07 '26	Sale	175.84	1,434	252,155	91,705	Jan 08 05:20 PM
Lewis William	Chair and CEO	Jan 06 '26	Sale	173.33	4,096	709,960	320,987	Jan 08 05:20 PM
Lewis William	Chair and CEO	Jan 08 '26	Sale	174.17	3,223	561,350	315,407	Jan 08 05:20 PM
Lewis William	Chair and CEO	Jan 07 '26	Sale	175.07	2,357	412,640	318,630	Jan 08 05:20 PM
Smith Michael Alexander	Chief Legal Officer	Jan 06 '26	Sale	173.33	1,396	241,969	58,799	Jan 08 05:19 PM
Smith Michael Alexander	Chief Legal Officer	Jan 08 '26	Sale	174.17	1,053	183,401	57,037	Jan 08 05:19 PM
Smith Michael Alexander	Chief Legal Officer	Jan 07 '26	Sale	175.07	709	124,125	58,090	Jan 08 05:19 PM
Michael Smith	Officer	Jan 08 '26	Proposed Sale	174.17	1,053	183,401		Jan 08 05:19 PM
William Lewis	Officer	Jan 08 '26	Proposed Sale	174.17	3,223	561,349		Jan 08 05:08 PM
Roger Adsett	Officer	Jan 07 '26	Proposed Sale	175.07	802	140,406		Jan 07 05:10 PM
Michael Smith	Officer	Jan 07 '26	Proposed Sale	175.07	709	124,124		Jan 07 05:04 PM
William Lewis	Officer	Jan 07 '26	Proposed Sale	175.07	2,357	412,636		Jan 07 04:59 PM
Sara Bonstein	Officer	Jan 07 '26	Proposed Sale	175.17	1,678	293,935		Jan 07 04:42 PM
Martina Flammer	Officer	Jan 07 '26	Proposed Sale	175.84	1,434	252,154		Jan 07 04:42 PM
Sara Bonstein	Officer	Jan 06 '26	Proposed Sale	173.33	1,517	262,941		Jan 06 04:40 PM
Martina Flammer	Officer	Jan 06 '26	Proposed Sale	173.33	1,615	279,927		Jan 06 04:37 PM
Roger Adsett	Officer	Jan 06 '26	Proposed Sale	173.33	1,429	247,688		Jan 06 04:33 PM
Michael Smith	Officer	Jan 06 '26	Proposed Sale	173.33	1,396	241,969		Jan 06 04:26 PM
William Lewis	Officer	Jan 06 '26	Proposed Sale	173.33	4,096	709,959		Jan 06 04:20 PM
Flammer Martina M.D.	Chief Medical Officer	Jan 05 '26	Option Exercise	25.80	12,303	317,465	107,057	Jan 06 04:06 PM
Flammer Martina M.D.	Chief Medical Officer	Jan 05 '26	Sale	171.38	12,303	2,108,507	94,754	Jan 06 04:06 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	Jan 02 '26	Option Exercise	13.91	87,290	1,214,204	129,044	Jan 06 04:03 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	Jan 02 '26	Sale	175.20	87,290	15,293,422	41,754	Jan 06 04:03 PM
Martina Flammer	Officer	Jan 05 '26	Proposed Sale	171.39	20,873	3,577,423		Jan 05 04:33 PM
Stacey Nicole Schaeffer Orlov	Officer	Jan 02 '26	Proposed Sale	175.11	87,290	15,285,351		Jan 02 04:29 PM
Lewis William	Chair and CEO	Dec 18 '25	Option Exercise	24.94	10,699	266,840	314,610	Dec 19 04:12 PM
Lewis William	Chair and CEO	Dec 18 '25	Sale	166.97	10,699	1,786,457	303,911	Dec 19 04:12 PM
William Lewis	Officer	Dec 18 '25	Proposed Sale	166.97	10,699	1,786,437		Dec 18 04:45 PM
SHAROKY MELVIN MD	Director	Dec 05 '25	Sale	205.01	20,000	4,100,200	243,948	Dec 09 04:05 PM
MELVIN SHAROKY	DIRECTOR	Dec 05 '25	Proposed Sale	205.00	20,000	4,100,000		Dec 05 05:39 PM
Lewis William	Chair and CEO	Dec 04 '25	Option Exercise	24.94	10,699	266,840	314,610	Dec 05 04:11 PM
Lewis William	Chair and CEO	Dec 04 '25	Sale	205.62	10,699	2,199,915	303,911	Dec 05 04:11 PM
William Lewis	Officer	Dec 04 '25	Proposed Sale	205.59	10,699	2,199,583		Dec 04 05:10 PM
Flammer Martina M.D.	Chief Medical Officer	Dec 01 '25	Option Exercise	25.83	8,895	229,758	92,006	Dec 03 04:01 PM
Flammer Martina M.D.	Chief Medical Officer	Dec 01 '25	Sale	206.98	8,895	1,841,101	83,111	Dec 03 04:01 PM
Martina Flammer	Officer	Dec 01 '25	Proposed Sale	206.95	8,895	1,840,841		Dec 01 04:08 PM
ANDERSON ELIZABETH M	Director	Nov 24 '25	Sale	204.58	5,000	1,022,900	58,729	Nov 26 04:31 PM
ANDERSON ELIZABETH M	Director	Nov 24 '25	Proposed Sale	204.00	5,000	1,020,000		Nov 24 03:07 PM
LEE LEO	Director	Nov 17 '25	Sale	195.90	75,000	14,692,249	54,677	Nov 18 04:21 PM
ANDERSON ELIZABETH M	Director	Nov 14 '25	Sale	195.87	10,000	1,958,700	63,729	Nov 18 04:20 PM
Leo Lee	Director	Nov 17 '25	Proposed Sale	193.22	75,000	14,491,500		Nov 17 05:29 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

INSM

Insmed Inc

Upgrade your Finviz experience